[ESBL-producing E. coli and EHEC in dogs and cats in the Tyrol as possible source of human infection].

In contrast to infections with enterohaemorrhagic E. coli (EHEC), which are thought to be classical zoonosis, the zoonotic potential of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae is still widely unknown. The aim of our study was to determine the frequency of EHEC and ESBL-producing Enterobacteriaceae in domestic animals (dogs and cats) in the Tyrol. Among 228 fecal samples of dogs (n = 92) and cats (n = 136) three samples (1.3%) were positive in the EHEC-ELISA. In two of the three cases isolation of the organism was not possible, the third sample of a two-year-old crossbreed bitch yielded EHEC O103:H2. In twelve of 228 (5.3%) fecal samples 13 ESBL-producing Enterobacteriaceae (in ten cats and two dogs) were found.These animals mainly derived from homes for animals (ten animals, 83%). 75% of the isolates belonged to the CTX-M-1-group, 8% to the CTX-M-2-group and 17% to the CTX-M-9-group. One isolate was positive for CTX-M-1 and CTX-M-9. Typing of the 13 ESBL-producing isolates by multilocus sequence typing (MLST) showed ten different sequence types, which points out the importance of the horizontal transfer of mainly plasmid-coded ESBL genes. Transmission of EHEC and ESBL-producing Enterobacteriaceae from domestic animals to humans is possible, corroborated by the fact that the EHEC serotype found in one dog and the sequence types detected by MLST in several dogs and cats were previously reported to occur in severe human infection.

[1]  S. Schwarz,et al.  Analysis of bla CTX-M-Carrying Plasmids from Escherichia coli Isolates Collected in the BfT-GermVet Study , 2011, Applied and Environmental Microbiology.

[2]  L. Wieler,et al.  Extended-spectrum beta-lactamases-producing gram-negative bacteria in companion animals: action is clearly warranted! , 2011, Berliner und Munchener tierarztliche Wochenschrift.

[3]  L. Wieler,et al.  Multidrug- and methicillin resistant Staphylococcus pseudintermedius as a cause of canine pyoderma: a case report. , 2010, Berliner und Munchener tierarztliche Wochenschrift.

[4]  D. Schifferli,et al.  First Detection of CTX-M and SHV Extended-Spectrum β-Lactamases in Escherichia coli Urinary Tract Isolates from Dogs and Cats in the United States , 2010, Antimicrobial Agents and Chemotherapy.

[5]  J. Weese,et al.  Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: A preliminary study. , 2009, The Canadian veterinary journal = La revue veterinaire canadienne.

[6]  B. Guerra,et al.  Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07. , 2009, The Journal of antimicrobial chemotherapy.

[7]  A. Friedrich,et al.  Staphylococcus aureus and MRSA colonization rates among personnel and dogs in a small animal hospital: association with nosocomial infections. , 2009, Berliner und Munchener tierarztliche Wochenschrift.

[8]  K. Lynch,et al.  Probable zoonotic transmission of verocytotoxigenic Escherichia coli O157 by dogs , 2009, Veterinary Record.

[9]  L. Martínez-Martínez,et al.  Detection of the Pandemic O25-ST131 Human Virulent Escherichia coli CTX-M-15-Producing Clone Harboring the qnrB2 and aac(6′)-Ib-cr Genes in a Dog , 2008, Antimicrobial Agents and Chemotherapy.

[10]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[11]  F. Aarestrup,et al.  Selection and Persistence of CTX-M-Producing Escherichia coli in the Intestinal Flora of Pigs Treated with Amoxicillin, Ceftiofur, or Cefquinome , 2008, Antimicrobial Agents and Chemotherapy.

[12]  M. Domínguez,et al.  Extended-spectrum beta-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. , 2008, Veterinary microbiology.

[13]  F. Aarestrup,et al.  Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria. , 2008, International journal of antimicrobial agents.

[14]  L. Vinué,et al.  Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets. , 2008, Veterinary microbiology.

[15]  M. Dierich,et al.  The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. , 2007, Diagnostic microbiology and infectious disease.

[16]  Daniel Falush,et al.  Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.

[17]  N. Woodford,et al.  Emergence of Enterobacteriaceae Isolates Producing CTX-M Extended-Spectrum β-Lactamase in Austria , 2006, Antimicrobial Agents and Chemotherapy.

[18]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[19]  M. Dierich,et al.  Importance of environmental transmission in cases of EHEC O157 causing hemolytic uremic syndrome , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[20]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[21]  M. C. Porrero,et al.  Monitoring and Characterization of Extended-Spectrum β-Lactamases in Escherichia coli Strains from Healthy and Sick Animals in Spain in 2003 , 2005, Antimicrobial Agents and Chemotherapy.

[22]  A. Carattoli,et al.  Extended-Spectrum β-Lactamases in Escherichia coli Isolated from Dogs and Cats in Rome, Italy, from 2001 to 2003 , 2005, Antimicrobial Agents and Chemotherapy.

[23]  Stefan Schwarz,et al.  Pet animals as reservoirs of antimicrobial-resistant bacteria. , 2004, The Journal of antimicrobial chemotherapy.

[24]  C. Hart,et al.  Prevalence of enteropathic Escherichia coli in dogs with acute and chronic diarrhoea , 2004, Veterinary Record.

[25]  P. McDermott,et al.  Characterization of Tn1546 in Vancomycin-Resistant Enterococcus faecium Isolated from Canine Urinary Tract Infections: Evidence of Gene Exchange between Human and Animal Enterococci , 2002, Journal of Clinical Microbiology.

[26]  L. Beutin,et al.  Genetic Diversity of Intimin Genes of Attaching and Effacing Escherichia coli Strains , 2002, Journal of Clinical Microbiology.

[27]  H. Karch,et al.  Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. , 2002, The Journal of infectious diseases.

[28]  L. Domínguez,et al.  Isolation of an SHV-12 β-Lactamase-Producing Escherichia coli Strain from a Dog with Recurrent Urinary Tract Infections , 2000, Antimicrobial Agents and Chemotherapy.

[29]  T. Besser,et al.  Multiple sources of Escherichia coli O157 in feedlots and dairy farms in the northwestern USA. , 1998, Preventive veterinary medicine.

[30]  C. Gyles,et al.  Detection of toxin genes in Escherichia coli isolated from normal dogs and dogs with diarrhea. , 1995, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[31]  L. Beutin,et al.  Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals , 1993, Journal of clinical microbiology.

[32]  Y. Yokota,et al.  Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins , 1988, Antimicrobial Agents and Chemotherapy.

[33]  J. Campos,et al.  Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. , 2010, Current opinion in infectious diseases.

[34]  A. Carattoli.  Animal reservoirs for extended spectrum beta-lactamase producers. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[35]  N. Woodford,et al.  The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. , 2006, Trends in microbiology.

[36]  E. Ferreira,et al.  Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. , 2002, The Journal of antimicrobial chemotherapy.

[37]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.